Retrospective Observational Study on Rebamipide Ophthalmic Suspension on Quality of Life of Dry Eye Disease Patients.

Yuri SakaneMasahiko YamaguchiAtsushi Shiraishi

Published in: Journal of ophthalmology (2019)

RBM treatment improves the QOL by alleviating the corneal and conjunctival epithelial damages. The DEQS is a useful questionnaire that can assess the severity of the DED symptoms and their impact on the QOL. This trial is registered with UMIN000024405.

Keyphrases

end stage renal disease
ejection fraction
cross sectional
newly diagnosed
chronic kidney disease
study protocol
prognostic factors
randomized controlled trial
sleep quality
phase ii